{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:55:14Z","timestamp":1793300114062,"version":"4.5.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Heart Lung Institute, Imperial College London"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107469\/Z\/15\/Z"],"award-info":[{"award-number":["107469\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Royal Brompton Biomedical Research Unit"},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is increasing understanding of the genetic basis to dilated cardiomyopathy and in this review, we offer a practical primer for the practising clinician. We aim to help all clinicians involved in the care of patients with dilated cardiomyopathy to understand the clinical relevance of the genetic basis of dilated cardiomyopathy, introduce key genetic concepts, explain which patients and families may benefit from genetic testing, which genetic tests are commonly performed, how to interpret genetic results, and the clinical applications of results. We conclude by reviewing areas for future research in this dynamic field.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab286","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T15:11:55Z","timestamp":1621350715000},"page":"2384-2396","source":"Crossref","is-referenced-by-count":52,"title":["Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know"],"prefix":"10.1093","volume":"42","author":[{"given":"Upasana","family":"Tayal","sequence":"first","affiliation":[{"name":"National Heart Lung Institute, Imperial College London , UK"},{"name":"Cardiovascular Research Centre, Royal Brompton & Harefield Hospitals , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-5880","authenticated-orcid":false,"given":"James S","family":"Ware","sequence":"additional","affiliation":[{"name":"National Heart Lung Institute, Imperial College London , UK"},{"name":"Cardiovascular Research Centre, Royal Brompton & Harefield Hospitals , London, UK"},{"name":"MRC London Institute of Medical Sciences , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6458-5421","authenticated-orcid":false,"given":"Neal K","family":"Lakdawala","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University , The Netherlands"},{"name":"Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology , Leuven, KU, Belgium"},{"name":"The Netherlands Heart Institute, Nl-HI , Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Prasad","sequence":"additional","affiliation":[{"name":"National Heart Lung Institute, Imperial College London , UK"},{"name":"Cardiovascular Research Centre, Royal Brompton & Harefield Hospitals , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"2022102602595545400_ehab286-B1","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"2022102602595545400_ehab286-B3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2022102602595545400_ehab286-B4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2011.06.022","article-title":"Review and metaanalysis of the frequency of familial dilated cardiomyopathy","volume":"108","author":"Petretta","year":"2011","journal-title":"Am J Cardiol"},{"key":"2022102602595545400_ehab286-B5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B6","doi-asserted-by":"crossref","first-page":"e000929","DOI":"10.1136\/openhrt-2018-000929","article-title":"Heritability in genetic heart disease: the role of genetic background","volume":"6","author":"Jansweijer","year":"2019","journal-title":"Open Heart"},{"key":"2022102602595545400_ehab286-B7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic etiology for alcohol-induced cardiac toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102602595545400_ehab286-B8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MOP.0000000000000533","article-title":"Genetics of paediatric cardiomyopathies","volume":"29","author":"Ware","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"2022102602595545400_ehab286-B9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cardfail.2012.01.017","article-title":"Pediatric cardiomyopathy: importance of genetic and metabolic evaluation","volume":"18","author":"Kindel","year":"2012","journal-title":"J Card Fail"},{"key":"2022102602595545400_ehab286-B10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11936-019-0739-y","article-title":"An update on pediatric cardiomyopathy","volume":"21","author":"Choudhry","year":"2019","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2022102602595545400_ehab286-B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ppedcard.2014.10.003","article-title":"Genetic causes of dilated cardiomyopathy","volume":"37","author":"Mestroni","year":"2014","journal-title":"Prog Pediatr Cardiol"},{"key":"2022102602595545400_ehab286-B12","first-page":"1993","volume-title":"GeneReviews\u00ae.","author":"Hershberger","year":"2007"},{"key":"2022102602595545400_ehab286-B13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-017-0410-8","article-title":"Genetics and genomics of dilated cardiomyopathy and systolic heart failure","volume":"9","author":"Tayal","year":"2017","journal-title":"Genome Med"},{"key":"2022102602595545400_ehab286-B14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"2022102602595545400_ehab286-B15","author":"Jordan","year":"2020"},{"key":"2022102602595545400_ehab286-B16","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2022102602595545400_ehab286-B17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","article-title":"Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield","volume":"21","author":"Thomson","year":"2019","journal-title":"Genet Med"},{"key":"2022102602595545400_ehab286-B18","doi-asserted-by":"crossref","first-page":"e24634","DOI":"10.7554\/eLife.24634","article-title":"Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes","volume":"6","author":"Alamo","year":"2017","journal-title":"Elife"},{"key":"2022102602595545400_ehab286-B19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41551-019-0348-9","article-title":"Combinatorial interactions of genetic variants in human cardiomyopathy","volume":"3","author":"Deacon","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"2022102602595545400_ehab286-B20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ejhg.2013.16","article-title":"Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy","volume":"21","author":"Roncarati","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"2022102602595545400_ehab286-B21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","article-title":"Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification","volume":"66","author":"Hazebroek","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022102602595545400_ehab286-B22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15252\/emmm.201707838","article-title":"Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy","volume":"10","author":"Haas","year":"2018","journal-title":"EMBO Mol Med"},{"key":"2022102602595545400_ehab286-B23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41436-018-0084-7","article-title":"Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy","volume":"21","author":"Minoche","year":"2019","journal-title":"Genet Med"},{"key":"2022102602595545400_ehab286-B24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41598-017-18524-2","article-title":"Putative functional genes in idiopathic dilated cardiomyopathy","volume":"8","author":"Nair","year":"2018","journal-title":"Sci Rep"},{"key":"2022102602595545400_ehab286-B25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bmj.322.7293.1052","article-title":"The complexities of predictive genetic testing","volume":"322","author":"Evans","year":"2001","journal-title":"BMJ"},{"key":"2022102602595545400_ehab286-B26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","article-title":"Genetic testing for dilated cardiomyopathy in clinical practice","volume":"18","author":"Lakdawala","year":"2012","journal-title":"J Card Fail"},{"key":"2022102602595545400_ehab286-B27","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B28","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"2022102602595545400_ehab286-B29","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/j.fertnstert.2017.07.800","article-title":"Preimplantation genetic diagnosis (PGD) for borderline indications including human leukocyte antigens (HLA) matching, cancer predisposition, cardiac disease and their proportion in overall PGD cases for single gene disorders","volume":"108","author":"Baxi","year":"2017","journal-title":"Fertil Steril"},{"key":"2022102602595545400_ehab286-B30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rbmo.2011.12.009","article-title":"PGD for inherited cardiac diseases","volume":"24","author":"Kuliev","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2022102602595545400_ehab286-B31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"2022102602595545400_ehab286-B32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"key":"2022102602595545400_ehab286-B33","doi-asserted-by":"crossref","first-page":"e004682","DOI":"10.1161\/CIRCHEARTFAILURE.117.004682","article-title":"Prevalence of pathogenic gene mutations and prognosis do not differ in isolated left ventricular dysfunction compared with dilated cardiomyopathy","volume":"11","author":"Hazebroek","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2022102602595545400_ehab286-B34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102602595545400_ehab286-B35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ejhg.2014.116","article-title":"The role of the genetic counsellor: a systematic review of research evidence","volume":"23","author":"Skirton","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"2022102602595545400_ehab286-B36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2022102602595545400_ehab286-B37","first-page":"3461","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamacardio.2017.5333","article-title":"Association of racial\/ethnic categories with the ability of genetic tests to detect a cause of cardiomyopathy","volume":"3","author":"Landry","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2022102602595545400_ehab286-B39","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2022102602595545400_ehab286-B40","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2022102602595545400_ehab286-B41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"2022102602595545400_ehab286-B42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12688\/wellcomeopenres.15090.2","article-title":"Genomic variant sharing: a position statement","volume":"4","author":"Wright","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2022102602595545400_ehab286-B43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am Heart J"},{"key":"2022102602595545400_ehab286-B44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"2022102602595545400_ehab286-B45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B46","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00761","article-title":"The broad spectrum of LMNA cardiac diseases: from molecular mechanisms to clinical phenotype","volume":"11","author":"Crasto","year":"2020","journal-title":"Front Physiol"},{"key":"2022102602595545400_ehab286-B47","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N Engl J Med"},{"key":"2022102602595545400_ehab286-B48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","article-title":"Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A\/C defect-related disease","volume":"39","author":"Arbustini","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102602595545400_ehab286-B49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022102602595545400_ehab286-B50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"2022102602595545400_ehab286-B51","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022102602595545400_ehab286-B52","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"2022102602595545400_ehab286-B53","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation","volume":"21","author":"Muchir","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2022102602595545400_ehab286-B54","first-page":"P4981","article-title":"Phase 2 study of a797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin a\/c-related dilated cardiomyopathy","volume":"37","author":"MacRae","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B55","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102602595545400_ehab286-B56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat Genet"},{"key":"2022102602595545400_ehab286-B57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"2022102602595545400_ehab286-B58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"key":"2022102602595545400_ehab286-B59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/HCO.0000000000000629","article-title":"Polygenic risk scores in coronary artery disease","volume":"34","author":"Rao","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"2022102602595545400_ehab286-B60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2019.03.028","article-title":"Polygenic prediction of weight and obesity trajectories from birth to adulthood","volume":"177","author":"Khera","year":"2019","journal-title":"Cell"},{"key":"2022102602595545400_ehab286-B61","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cvr\/cvy122","article-title":"Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"Bondue","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022102602595545400_ehab286-B62","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00424-018-2173-5","article-title":"Gene therapy strategies in the treatment of hypertrophic cardiomyopathy","volume":"471","author":"Prondzynski","year":"2019","journal-title":"Pflugers Arch"},{"key":"2022102602595545400_ehab286-B63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.118.036965","article-title":"Allele-specific silencing ameliorates restrictive cardiomyopathy attributable to a human myosin regulatory light chain mutation","volume":"140","author":"Zaleta-Rivera","year":"2019","journal-title":"Circulation"},{"key":"2022102602595545400_ehab286-B64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42466-020-00075-z","article-title":"Gene specific therapies\u2014the next therapeutic milestone in neurology","volume":"2","author":"Brenner","year":"2020","journal-title":"Neurol Res Pract"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/24\/2384\/46633306\/ehab286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/24\/2384\/46633306\/ehab286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T23:01:49Z","timestamp":1666738909000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/24\/2384\/6307392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":64,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,6,21]]},"published-print":{"date-parts":[[2021,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab286","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,21]]},"published":{"date-parts":[[2021,6,21]]}}}